nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Sumatriptan—ABCB1—adrenal gland cancer	0.0884	0.553	CrCbGaD
Zolmitriptan—Eletriptan—ABCB1—adrenal gland cancer	0.0715	0.447	CrCbGaD
Zolmitriptan—MAOA—Dopamine metabolism—PRKACA—adrenal gland cancer	0.061	0.0726	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCRs, Other—GNRHR—adrenal gland cancer	0.0598	0.0711	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0222	0.0265	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0179	0.0213	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0169	0.0202	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0142	0.0169	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0139	0.0166	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—KCNJ5—adrenal gland cancer	0.0137	0.0163	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0133	0.0159	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0119	0.0141	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0108	0.0129	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0106	0.0126	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0106	0.0126	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0101	0.0121	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00957	0.0114	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—TSHR—adrenal gland cancer	0.00905	0.0108	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00869	0.0103	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00869	0.0103	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00852	0.0101	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00835	0.00994	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00834	0.00993	CbGpPWpGaD
Zolmitriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00829	0.00986	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00808	0.00962	CbGpPWpGaD
Zolmitriptan—MAOA—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00793	0.00944	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0076	0.00904	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00744	0.00885	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0071	0.00845	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00684	0.00815	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00649	0.00773	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00636	0.00757	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00635	0.00756	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00612	0.00729	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00599	0.00714	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00585	0.00697	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—TSHR—adrenal gland cancer	0.00578	0.00689	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00573	0.00683	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00567	0.00674	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00566	0.00674	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00556	0.00662	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00556	0.00662	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00544	0.00648	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00544	0.00648	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—GNAS—adrenal gland cancer	0.00526	0.00626	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—PRKACA—adrenal gland cancer	0.00524	0.00624	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00521	0.0062	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GNRHR—adrenal gland cancer	0.00514	0.00611	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00511	0.00609	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00484	0.00576	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00477	0.00568	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00465	0.00554	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—TSHR—adrenal gland cancer	0.00464	0.00553	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00457	0.00544	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00449	0.00534	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00433	0.00516	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00431	0.00514	CbGpPWpGaD
Zolmitriptan—MAOA—Biological oxidations—POMC—adrenal gland cancer	0.00421	0.00502	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00415	0.00494	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00415	0.00493	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SDHB—adrenal gland cancer	0.00377	0.00449	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00374	0.00445	CbGpPWpGaD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00369	0.00439	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00367	0.00437	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00366	0.00436	CbGpPWpGaD
Zolmitriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00361	0.0043	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00359	0.00428	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00356	0.00424	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—POMC—adrenal gland cancer	0.00354	0.00422	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—GNAS—adrenal gland cancer	0.00336	0.00401	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00333	0.00397	CbGpPWpGaD
Zolmitriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00333	0.00397	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00333	0.00396	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—GNAS—adrenal gland cancer	0.00329	0.00392	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GNRHR—adrenal gland cancer	0.00328	0.00391	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00327	0.00389	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00326	0.00388	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00325	0.00387	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GNRHR—adrenal gland cancer	0.00322	0.00383	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0032	0.00381	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00311	0.0037	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GNRH1—adrenal gland cancer	0.00308	0.00366	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00305	0.00363	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00299	0.00356	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00297	0.00354	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00297	0.00354	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—TSHR—adrenal gland cancer	0.00297	0.00353	CbGpPWpGaD
Zolmitriptan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00293	0.00348	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00291	0.00347	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00291	0.00346	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00287	0.00342	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—BRAF—adrenal gland cancer	0.00283	0.00336	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CDC42—adrenal gland cancer	0.00283	0.00336	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SPRY2—adrenal gland cancer	0.00281	0.00335	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00281	0.00335	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00279	0.00332	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00276	0.00329	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TSHR—adrenal gland cancer	0.00274	0.00326	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00274	0.00326	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—GNAS—adrenal gland cancer	0.0027	0.00321	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MEN1—adrenal gland cancer	0.00258	0.00307	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00252	0.003	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00252	0.003	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00251	0.00299	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00248	0.00296	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00245	0.00292	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00244	0.0029	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SDHD—adrenal gland cancer	0.00243	0.00289	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—RRM1—adrenal gland cancer	0.00243	0.00289	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00228	0.00271	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—POMC—adrenal gland cancer	0.00227	0.0027	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00222	0.00264	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—POMC—adrenal gland cancer	0.00222	0.00264	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00221	0.00264	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00214	0.00255	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00213	0.00254	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00209	0.00248	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—POMC—adrenal gland cancer	0.002	0.00238	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00199	0.00237	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PRKACA—adrenal gland cancer	0.00197	0.00234	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GNRH1—adrenal gland cancer	0.00197	0.00234	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00195	0.00232	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00193	0.00229	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0019	0.00226	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00186	0.00222	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—POMC—adrenal gland cancer	0.00182	0.00216	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MED12—adrenal gland cancer	0.00181	0.00216	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CDC42—adrenal gland cancer	0.00181	0.00215	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SPRY2—adrenal gland cancer	0.0018	0.00214	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00177	0.00211	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00176	0.0021	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TSHR—adrenal gland cancer	0.00175	0.00209	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GNAS—adrenal gland cancer	0.00173	0.00206	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TSHR—adrenal gland cancer	0.00172	0.00204	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00169	0.00201	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	0.00169	0.00201	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDC42—adrenal gland cancer	0.00167	0.00199	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MEN1—adrenal gland cancer	0.00165	0.00196	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MEN1—adrenal gland cancer	0.00161	0.00192	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF2—adrenal gland cancer	0.00161	0.00192	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GNAS—adrenal gland cancer	0.0016	0.0019	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00159	0.00189	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF1R—adrenal gland cancer	0.00156	0.00185	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.00155	0.00185	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.0015	0.00178	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00148	0.00177	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00147	0.00175	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00142	0.00169	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.00139	0.00165	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00135	0.0016	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00134	0.0016	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TERT—adrenal gland cancer	0.00134	0.00159	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PRKACA—adrenal gland cancer	0.00132	0.00157	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	0.00131	0.00156	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00129	0.00153	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.00128	0.00152	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.00126	0.0015	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.00125	0.00149	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.00123	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	0.00123	0.00146	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—BAD—adrenal gland cancer	0.00116	0.00139	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—POMC—adrenal gland cancer	0.00116	0.00138	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	0.00114	0.00136	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00109	0.0013	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—POMC—adrenal gland cancer	0.00107	0.00128	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GNAS—adrenal gland cancer	0.00107	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDC42—adrenal gland cancer	0.00107	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—BRAF—adrenal gland cancer	0.00106	0.00126	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ABCB1—adrenal gland cancer	0.00105	0.00125	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	0.00105	0.00124	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	0.00103	0.00122	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—EGFR—adrenal gland cancer	0.00103	0.00122	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	0.00102	0.00121	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.00101	0.0012	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000999	0.00119	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000995	0.00118	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000974	0.00116	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000955	0.00114	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000939	0.00112	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.000896	0.00107	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.000896	0.00107	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000867	0.00103	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	0.000856	0.00102	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000839	0.000998	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000796	0.000948	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000767	0.000914	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000766	0.000912	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000761	0.000906	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	0.000745	0.000887	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000742	0.000883	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000729	0.000868	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—POMC—adrenal gland cancer	0.000721	0.000858	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.000687	0.000818	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000678	0.000807	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000672	0.000801	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000668	0.000795	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000664	0.000791	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000657	0.000783	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000644	0.000766	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000639	0.00076	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—adrenal gland cancer	0.000607	0.000723	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000597	0.000711	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—adrenal gland cancer	0.000575	0.000684	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000556	0.000662	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.000512	0.00061	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—adrenal gland cancer	0.00051	0.000607	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000506	0.000602	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.00049	0.000584	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00049	0.000584	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000487	0.00058	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00048	0.000571	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000476	0.000567	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.000395	0.00047	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000388	0.000462	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	0.000387	0.000461	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	0.00038	0.000453	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000366	0.000435	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	0.000326	0.000388	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	0.000319	0.00038	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	0.00029	0.000345	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—POMC—adrenal gland cancer	0.000266	0.000316	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	0.000243	0.00029	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	0.000212	0.000252	CbGpPWpGaD
